Exonate

United Kingdom
activeseed
Sign in to unlock
seed
Stage

About

Exonate is an early-stage biotech company developing innovative therapeutics that modify mRNA splicing, with a lead program targeting wet Age-Related Macular Degeneration in ophthalmology.

Explore Exonate's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing